Communicating a Cancer Diagnosis-Current Methods and Their Effects
- Conditions
- BehaviorCancer
- Registration Number
- NCT00674804
- Brief Summary
This study will investigate how patients are informed of their cancer diagnosis or recurrence and will explore their experience in learning about the diagnosis. Specifically, it will:
* Distinguish methods of telling the diagnosis and identify its relationship to the type of cancer.
* Determine if the way a patient is informed of their diagnosis is associated with their level of satisfaction with the method of being informed.
* Identify who informs the patient of their diagnosis..
* Determine patient satisfaction with their diagnostic consult.
* Identify indicators of satisfaction with the diagnostic consultation.
Patients 18 years of age or older who are enrolled in or being screened for enrollment in a phase I, II or III clinical trial in the National Cancer Institute's Medical Oncology, Metabolism, Surgery or Neuro-Oncology branch may be eligible for this study.
Participants complete a 15-minute questionnaire that includes questions related to the how they were informed of their cancer diagnosis.
- Detailed Description
Background:
- The goals of the study are to identify how a patient with a diagnosis of cancer is informed of their condition and to illuminate the way in which this information exchange occurs.
Objectives:
To distinguish, identify and determine:
* If the method by which a patient is informed of a diagnosis of cancer is associated with their level of satisfaction with that method of being informed
* Who tells the patient of their condition
* The methods used to inform a patient of their condition
* Prognostic indicators of high satisfaction within the diagnostic consult
Eligibility:
* Patients currently enrolled or being screened for enrollment for a phase I, II or III clinical trial at the National Cancer Institutes clinic center- specifically, within the following branch clinics: Medical Oncology, Metabolism, Surgery and Neuro-Oncology.
* Patient must be 18 years or older and be willing to participate in the study.
Design:
* Primary methodological practice is a self-administered questionnaire.
* Questionnaire to be completed by patient on same day that it is administered at NCI.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1100
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
🇺🇸Bethesda, Maryland, United States